Lumata Health Secures $23 Million Series B Funding to Expand Vision-Saving Technology

Lumata Health has raised $23 million in Series B funding, bringing its total funding to $36 million since inception. This investment will help the company expand its data-driven patient adherence solutions aimed at preventing blindness and improving access to vision-saving treatments.

Scaling Data-Driven Patient Adherence Solutions

Lumata Health focuses on overcoming systemic barriers that prevent timely care for patients with sight-threatening conditions. By leveraging predictive analytics and personalized interventions, the platform has demonstrated the ability to facilitate up to 800 additional vision-saving eye injections annually per 1,000 participating patients. This proactive approach not only preserves eyesight but also significantly lowers long-term healthcare costs related to vision loss.

Investment & Strategic Growth

The Series B round was co-led by LRVHealth, McKesson Ventures, and Cencora Ventures, with additional backing from existing investors, including Cortado Ventures. This funding will enable Lumata Health to scale its technology and meet the growing demand for its solutions.

CEO’s Vision for the Future

Landon Grace, CEO of Lumata Health, emphasized the impact of the funding:

“We are thrilled to partner with investors who share our vision for a smarter, more effective approach to preventing blindness from chronic eye diseases. This investment will allow us to continue scaling our data-driven approach to ensuring access and adherence to vision-saving treatments for the millions of people in the US with these conditions.”

Transforming Eye Care Nationwide

Over the last three years, Lumata Health has expanded its reach by collaborating with leading eye care providers across the United States, including the five largest national and regional eye care networks.

Investor Perspective

Ellen Herlacher, Partner at LRVHealth, highlighted why the firm chose to invest in Lumata Health:

“With millions of Americans at risk of preventable blindness, we’re investing in Lumata Health because it is uniquely positioned to drive meaningful change at scale. By combining advanced technology, predictive analytics, and compassionate care, the company is reshaping how chronic eye diseases are managed and ensuring that more patients retain their vision for years to come.”

Conclusion

With this latest funding round, Lumata Health is poised to further revolutionize patient adherence and access to sight-saving treatments. The company’s continued expansion will help bridge critical gaps in care, leveraging innovative technology to prevent blindness and improve patient outcomes across the country.